Results 191 to 200 of about 6,040 (212)

The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile

Diabetes, Obesity and Metabolism, 2005
Bart Staels
exaly  

Rimonabant: obituary for a wonder drug

The Lancet, 2010
Boekholdt, S. Matthijs, Peters, Ron J. G.   +1 more
openaire   +2 more sources

Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users

Psychopharmacology, 2007
Marilyn A Huestis, Stephen J Heishman, Kenzie L Preston   +2 more
exaly  

Rimonabant: The first therapeutically relevant cannabinoid antagonist

Life Sciences, 2005
Mauro A M Carai, Giancarlo Colombo, Gian Luigi Gessa   +2 more
exaly  

Rimonabant Caution

JAMA, 2007
openaire   +1 more source

Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway

Acta Pharmacologica Sinica, 2010
Nan-Lan Huang, Jyh-Ming Jimmy Juang, Chia-Ti Tsai   +2 more
exaly  

Sub-chronic administration of rimonabant causes loss of antidepressive activity and decreases doublecortin immunoreactivity in the mouse hippocampus

Neuroscience Letters, 2009
Seungjoo Lee, Sung-Hwa Yoon, Jong Hoon Ryu   +2 more
exaly  

Rimonabant/sibutramine

Reactions Weekly, 2008
openaire   +1 more source

CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant

Journal of Neuroendocrinology, 2008
André J Scheen
exaly  

Rimonabant

2016
openaire   +1 more source